Proto Script Pharmaceutical Corp. (PSCR)

PSCR Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014
Period Ending	Sep 30, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Revenue	0.6	0.79	0.88	0.95
Revenue Growth (YoY)	-32.96%	-10.49%	-7.02%	-
Cost of Revenue	0.25	0.22	0.19	0.26
Gross Profit	0.35	0.56	0.69	0.69
Selling, General & Admin	1.32	0.86	0.84	0.92
Operating Expenses	1.32	0.86	0.84	0.92
Operating Income	-0.97	-0.3	-0.15	-0.23
Other Non Operating Income (Expenses)	0.12	-	0	-0.01
EBT Excluding Unusual Items	-1.5	-0.3	-0.15	-0.24
Other Unusual Items	-6.88	-6.88	-	-
Pretax Income	-8.39	-7.18	-0.15	-0.24
Net Income	-8.39	-7.18	-0.15	-0.24
Net Income to Common	-8.39	-7.18	-0.15	-0.24
Shares Outstanding (Basic)	145	316	300	1
Shares Outstanding (Diluted)	145	316	300	1
Shares Change (YoY)	-52.98%	5.43%	29900.00%	-
EPS (Basic)	-0.06	-0.02	-0.00	-0.24
EPS (Diluted)	-0.06	-0.02	-0.00	-0.24
Free Cash Flow	-0.34	0.03	0.03	-0.12
Free Cash Flow Per Share	-0.00	-	-	-0.12
Gross Margin	58.15%	71.55%	78.77%	72.75%
Operating Margin	-160.49%	-37.78%	-16.64%	-24.48%
Profit Margin	-1386.22%	-910.40%	-16.48%	-25.23%
Free Cash Flow Margin	-55.69%	3.66%	3.63%	-13.11%
EBITDA	-0.96	-0.29	-0.07	-0.14
EBITDA Margin	-159.11%	-37.13%	-8.04%	-15.17%
D&A For EBITDA	0.01	0.01	0.08	0.09
EBIT	-0.97	-0.3	-0.15	-0.23
EBIT Margin	-160.49%	-37.78%	-16.64%	-24.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.